These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6659713)

  • 21. [beta Phenylethylamine: psychopharmacological and clinical aspects].
    Nakagawara M
    Yakubutsu Seishin Kodo; 1986 Sep; 6(3):295-307. PubMed ID: 3101312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neonatal depletion of cortical dopamine: effects on dopamine turnover and motor behavior in juvenile and adult rats.
    Boyce PJ; Finlay JM
    Brain Res Dev Brain Res; 2005 May; 156(2):167-75. PubMed ID: 16099303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in brain catecholamine metabolism during bromocriptine treatment in polycystic ovary syndrome.
    Paradisi R; Grossi G; Venturoli S; Porcu E; Rocchi G; Pasquali R; Capelli M; Flamigni C
    Horm Res; 1993; 39(5-6):223-8. PubMed ID: 8314207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The level of catecholamines and dihydroxyphenylacetic acid in the brain of rats with a hereditary predisposition to catalepsy].
    Alekhina TA; Gilinskiĭ MA; Kolpakov VG
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1995; 45(1):180-4. PubMed ID: 7754690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Changes in monoamine and monoamine metabolites in the nucleus accumbens and locomotor activity caused by p-chloroamphetamine: studies with intracerebral dialysis in freely moving rats].
    Sugita R; Terada K; Sekiya Y; Sawa Y; Nomura S
    Seishin Shinkeigaku Zasshi; 1993; 95(7):507-22. PubMed ID: 8234533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoaminergic dysregulation in glutathione-deficient mice: possible relevance to schizophrenia?
    Jacobsen JP; Rodriguiz RM; Mørk A; Wetsel WC
    Neuroscience; 2005; 132(4):1055-72. PubMed ID: 15857710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysophosphatidylcholine decreases locomotor activities and dopamine turnover rate in rats.
    Lee ES; Soliman KF; Charlton CG
    Neurotoxicology; 2005 Jan; 26(1):27-38. PubMed ID: 15527871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
    Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
    Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
    Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ
    J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased stress response and beta-phenylethylamine in MAOB-deficient mice.
    Grimsby J; Toth M; Chen K; Kumazawa T; Klaidman L; Adams JD; Karoum F; Gal J; Shih JC
    Nat Genet; 1997 Oct; 17(2):206-10. PubMed ID: 9326944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of tyrosine on brain catecholamine turnover in reserpine-treated rats.
    Oishi T; Wurtman RJ
    J Neural Transm; 1982; 53(2-3):101-8. PubMed ID: 7077311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N,N-dipropargyl-2-phenylethylamine, a potential prodrug of 2-phenylethylamine: neurochemical and neuropharmacological studies in rat.
    Rao TS; Baker GB; Coutts RT
    Brain Res Bull; 1987 Jul; 19(1):47-55. PubMed ID: 3651840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of ethanol on the brain catecholamine systems in female mice, rats, and guinea pigs.
    Alari L; Lewander T; Sjöquist B
    Alcohol Clin Exp Res; 1987 Apr; 11(2):144-9. PubMed ID: 3296831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral effects of β-phenylethylamine and various monomethylated and monohalogenated analogs in mice are mediated by catecholaminergic mechanisms.
    Mosnaim AD; Hudzik T; Wolf ME
    Am J Ther; 2015; 22(6):412-22. PubMed ID: 26544964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of narcotic analgesics upon the locomotor activity and brain catecholamine content of the mouse.
    Rethy CR; Smith CB; Villarreal JE
    J Pharmacol Exp Ther; 1971 Feb; 176(2):472-9. PubMed ID: 5568788
    [No Abstract]   [Full Text] [Related]  

  • 36. Differences in catecholamine metabolism and behaviour in neonatal broiler and layer chicks.
    Saito S; Takagi T; Koutoku T; Saito ES; Hirakawa H; Tomonaga S; Tachibana T; Denbow DM; Furuse M
    Br Poult Sci; 2004 Apr; 45(2):158-62. PubMed ID: 15222411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of central actions of intraventricularly administered octopamine, phenylethylamine and adrenaline in rats.
    Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1983; 35(1):59-62. PubMed ID: 6412221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracerebral dialysis coupled to a novel activity box--a method to monitor dopamine release during behaviour.
    Sharp T; Ljungberg T; Zetterström T; Ungerstedt U
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1755-9. PubMed ID: 3737640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropharmacological and neurochemical properties of N-(2-cyanoethyl)-2-phenylethylamine, a prodrug of 2-phenylethylamine.
    Baker GB; Coutts RT; Rao TS
    Br J Pharmacol; 1987 Oct; 92(2):243-55. PubMed ID: 2890391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methamphetamine-induced behavioral effects and releases of brain catecholamines and brain concentrations of methamphetamine in mice.
    Yamanaka Y; Yamamoto T; Egashira T
    Jpn J Pharmacol; 1983 Feb; 33(1):33-40. PubMed ID: 6683768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.